Kim Joseph Jong's most recent trade in Inovio Pharmaceuticals Inc was a trade of 139,387 Common Stock done . Disclosure was reported to the exchange on March 11, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inovio Pharma Inc | Kim Joseph Jong | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2022 | 139,387 | 1,462,325 (1%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Kim Joseph Jong | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2022 | 139,387 | 139,386 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Kim Joseph Jong | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.22 per share. | 11 Mar 2022 | 39,698 | 1,422,627 (1%) | 0% | 3.2 | 127,828 | Common Stock |
| Inovio Pharma Inc | Kim Joseph Jong | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 63,700 | 1,341,080 (1%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Kim Joseph Jong | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2022 | 63,700 | 0 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Kim Joseph Jong | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.26 per share. | 08 Mar 2022 | 18,142 | 1,322,938 (1%) | 0% | 3.3 | 59,143 | Common Stock |
| Inovio Pharma Inc | Kim Joseph Jong | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2022 | 627,700 | 627,700 | - | - | Common Stock Option | |
| Inovio Pharma Inc | Kim Joseph Jong | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2022 | 468,500 | 468,500 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Kim Joseph Jong | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2022 | 68,767 | 1,297,425 (1%) | 0% | - | Common Stock | |
| Inovio Pharma Inc | Kim Joseph Jong | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2022 | 68,767 | 137,533 | - | - | Restricted Stock Unit | |
| Inovio Pharma Inc | Kim Joseph Jong | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.22 per share. | 26 Feb 2022 | 20,045 | 1,277,380 (1%) | 0% | 3.2 | 64,545 | Common Stock |